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Background: Outcomes after open esophagectomy (OE) have been shown to depend on 
institution case volume.  We aim to determine whether a similar relationship exists for minimally-
invasive esophagogastrectomy (MIE). 
Methods: Patients who had OE or MIE (excluding robotic procdures) between 2010 and 2013 
in the National Cancer Database were included. Outcomes included 30- and 90-day mortality, 
length-of-stay, hospital readmission, margin positivity, and number of lymph nodes harvested.  
Logistic and linear regression were used to adjust for possible confounders including age, 
gender, tumor size, Charlson score, induction therapy, and type of institution (academic vs. 
community-based).   
Results: We identified 2371 patients in the MIE group and 6285 patients in the OE group.  In 
multivariate analysis, high case volume was an independent predictor for lower 30-day, 90-day 
mortality, shorter length-of-stay, and higher rate of negative-margin resection in OE (P<0.001) 
but not MIE.  After quartile ranking of institutions based on volume, MIE outcomes were found to 
be better in institutions in the highest volume quartile compared to those in the lowest (p< 
0.0001).   
Conclusions: In this dataset, MIE postoperative outcomes, unlike OE, did not correlate with 
hospital case volume.  Volume-outcome relationships may be affected by surgical approach.  
The effect of case volume on long-term outcomes after MIE warrants further study. 














Esophageal carcinoma typically presents with locally-advanced or metastatic disease 
precluding surgical resection1-4. For early-stage tumors, esophagogastrectomy (EG) is the best 
option for cure despite carrying significant risks and post-operative complications compared to 
other operations with similar complexity1,2,4.  Within the past decade, minimally-invasive (MIE) 
esophagogastrectomy has gained increasing popularity due to decreased post-operative pain 
and lengt-of-stay while maintaining similar outcomes when compared to the traditional open 
approach5-22. However, MIE has an extensive learning curve, and typically are performed 
routinely only at tertiary referral centers with high-volume15-19.  While previous reports indicated 
a direct correlation between open EG case volume and operative outcome20-28, no studies have 
evaluated this relationship in MIE.  The primary goal of this study is to determine whether short-
term and oncologic outcomes for minimally-invasive esophagogastrectomy for esophageal 
cancer is dependent on institutional case volume. 
Patients and Methods 
Patients 
The National Cancer Database (NCDB) is a de-identified clinical oncology hospital 
registry data from community, comprehensive community, and academic facilities.  Following an 
exemption granted by the local Institutional Review Board, the NCDB was queried for all 
esophagectomies performed between January 1 2010 through December 31, 2013.  We elected 
to begin with 2010 and not earlier due to the minimal implementation of MIE prior to this time 
period.  We chose to end data collection at 2013 to allow for a complete 5-year follow-up in our 
analyses.  Patients with concurrent laryngectomy, esophagogastrectomy with staged or non-
gastric conduits were excluded.  All included patients were categorized into laparoscopic (MIE), 
open (OE), or robotic.  Given the small number of robotic esophagectomies, this group was 















Demographics including age and gender, Charlson comorbidity index, neoadjuvant 
chemoradiation, clinical, and pathological T-stage were described using descriptive statistics.  
Pearson’s Chi-square and student’s t-tests were used to analyzed categorical and continuous 
variables, respectively.  Pooled multivariable logistic  and linear models were used to examine 
outcomes including 30 and 90-day mortality, R0 resection, 30-day readmissions, long-term 
survival, length-of-stay, number of regional nodes collected, and number of positive nodes.  All 
models were controlled for the effect of annual case volume and annual laparoscopic-to-open 
conversion rates in addition to preoperatibe characteristics.  Multicollinearity were tested and 
highly correlative variables were omitted from our final model28.  Casewise deletion was used for 
missing data.  Multivariable regression analysis were performed for MIE and OE subgroup. 
Volume analysis 
The institution annual esophagogastrectomy (MIE and OE) case volume and MIE  case 
volume during the study period were analyzed.  Quartiles were created with cut-offs at 25th, 50th, 
and 75th percentile.  For each outcome, we performed interquartile comparisons of the 
multivariable regression estimates.  
Propensity Score Matching 
To examine any differences in outcomes between MIE and OE that might explain 
differences in volume-outcome realtionships due to selection bias29, we used PSMATCH230 
command in Stata SE 14.2 to match each MIE to OE case without replacement.  The optimal 
caliper width31 of 0.10 to match age, gender, tumor size, Charlson’s comorbidity score, induction 
radiation and chemotherapy, and type of institution (academic versus community-based). 
Multivariable logistic and linear regressions were performed on the matched pairs. 
Kaplan-Meier survival analysis 
Using time from diagnosis to the last contact and/or death, we performed Kaplan-Meier 
(KM) analysis to estimate the survival function for unmatched and matched cohorts. Difference 















We identifiied 8656 cases of esophagogastrectomy performed between January 1, 2010 
through December 31, 2013.  6285 cases were performed open and 2371 cases were 
performed using the minimally-invasive approach.  The median volume of 
esophagogastrectomy performed per year per facility was 8 (range 1-113).  Similarly, the 
median volume of MIE performed per facility was 5 (range 1-42) with a mean conversion rate of 
3.3 cases per year.  
Cohorts 
Demographics and preoperative factors including tumor size, Charlson score, clinical 
and pathologic staging, and neoadjuvant chemotherapy and radiation are presented in Table 1.  
There was no differences in any of the aforementioned factors except for larger tumor size (35 
mm versus 31 mm, p<0.05) and higher clinical T-stage (p<0.006) in OE.  No differences in 
pathologic staging were noted.  In bivariate analysis, the MIE group was noted to have a shorter 
length-of-stay (LOS) (p<0.001), lower 30-day and 90-day mortality (p<0.05), higher number of 
lymph nodes collected (p< 0.001), and longer 5-year overall survival (p<0.05) as compared to 
the OE cohort (Table 2).  Multivariate regression analyses identified the MIE approach as an 
independent predictor of lower 30 and 90-day mortality, shorter LOS, higher number of 
examined lymph nodes and higher 5-year survival (p<0.05) (Table 3).   These findings persisted 
after propensity matching was performed accounting for age, gender, Charlson Comorbidity 
Index, tumor size, and stage (p<0.05) (Table 4).  
 When looking at all cases (open and MIE), multivariate analysis revealed that volume 
was found to be a predictor of all outcome variables except for 30-day readmission (Table 3).  
Further subgroup analyses indicated that case volume as a continuous variable was a 
significant predictor of all outcome measures for OE but not MIE (Supplemental Table 1).  
Conversion from MIE to open approach was associated with a slight increased in 30-day 














Volume quartile analysis.  
Institutions were ranked based on the number of total esophagogastrectomy performed 
annually.  The lowest quartile performed an average of 2.4 cases annually and the highest 
quartile performed an average of 42.5 cases per year (range 20-113 cases). Regression 
estimates were compared between all quartiles (Table 5).  The highest performing centers were 
found to have reduced 30-day [OR 0.44] and 90-day [OR 0.56] mortality when compared to the 
two lowest-performing quartiles (p<0.05).  Centers that performed 20 to 113 cases per year (4th 
quartile) also had shorter length-of-stay [OR -1.80, p<0.05], higher number of lymph nodes 
collected [OR 6.09, p<0.001], and lower rate of incomplete resection [OR 0.63, p<0.05] when 
compared to the first quartile (p< 0.05).  High-volume centers have decreased long-term 
mortality compared to all other quartiles (p<0.05) (Table 5).  These differences dissipated when 
institutions were ranked based on annual MIE cases (Supplemental Table 2).  Similar analyses 
were performed for matched cohorts and no significant differences were noted for any outcome 
variables except for the number of lymph nodes collected and long-term mortality (data not 
shown). 
Oncologic outcomes 
Case volume and MIE were positive independent predictors of the number of lymph 
nodes collected in both matched and unmatched cohorts (Table 3, 4).  Although no differences 
were found in final N-stage in pooled results, subgroup analyses revealed that case volume 
correlates with higher rate of R0 resection and number of collected and lymph nodes in OE but 
not MIE (Supplemental Table 1).  Interquartile comparisons revealed similar findings. 
Comment 
Analyses of the Medicare database in 2011 indicated that EG operative complications 
are inversely associated with institutional case volume and thus shifted the paradigm towards 
centralizing care for esophagogastrectomy20,21,32.  A similar relationship was recently noted 














suggested institutionally-derived benefits at tertiary care centers32,33. In the setting of rapid 
adoption of minimally-invasive esophagectomies across all institutions, we seek to define the 
effects of esophagogastrectomy case volume on MIE outcomes. 
The NCDB database provided a robust multi-institutional patient population capturing 
approximately 75 percent of cancer cases in the United states with data regarding type of 
operations, type of institutions, and case volume over several years.  Our study of this patient 
population corroborated findings from previous reports indicating that volume is an independent 
predictor of postoperative outcomes and mortality in all esophagectomy cases22-27.  However, 
subgroup analysis suggest that this relationship only holds true for open cases and volume as a 
continuous variable did not contribute an effect on minimally-invasive esophagectomy.  We 
further explored this relationship in a volume-outcome relationships were analyzed as a rank-
test.  Our quartile analysis suggested that differences in outcomes are only seen between the 
highest (4th quartile) and lowest (1st quartile) volume centers.  This suggests that marginal 
increases in volume is not a positive predictor of outcome and corroborates with the finding of a 
large challenging learning curve of MIE in that a threshold case volume is required to achieve a 
benefit in outcome34,35,36.  Previous studies determined that mortality benefits arise from high-
volume centers that perform at least 20 esophagogastrectomies annually as compared low-
volume institutions perform between 1 to 10 cases34,35.  These divisions correlated with our 
quartile rankings.  Even though our analysis did not determine a cut-off value for the number of 
cases required to improve outcome, it is reasonable to surmise rankings similar to previous 
study.  It is interesting to note that differences in outcomes are only noted when institutions were 
ranked based on total volume of esophagectomy cases (open and MI) performed per year.  
When institutions were ranked based only on the number of MI esophagectomies performed 
annually, no significant differences were detected in any outcome parameters.  These results 
suggest that outcomes for MIE rely on institutionally-derived benefits including multidisciplinary 














the institutional advantages have conferred to these cases and this needs to be explored in 
future studies36,37.   
Our Kaplain-Meier analysis revealed a long-term survival benefit for MIE patients in 
matched cohorts with case volume as a significant predictor.  This is independent of 
preoperative clinical staging, surgical margins, complete resection, lymph node status, and final 
pathology staging.  To our knowledge, this survival advantage has not been previously 
established. Of interest, the number of resected lymph nodes correlated with higher case 
volumes and was also higher in MIE cases. These effects of institutional case volume on long-
term survival warrant further study.    
Our study is limited in its retrospective nature and data errors inherent to national 
databases exist.  In addition, the NCDB database also had missing data in several fields 
including clinical staging, pathology, and accurate description of surgical procedure type.  The 
missingness of our clinical staging was approximately 2.30%.  There were 2.59% (n=224) 
patients with missing pathological stages.  To address this, as suggested in the NCDB Public 
Use File Data Dictionary, we used clinical stage to impute the tumor staging.  After this 
imputation, we had only 2.26% (n=196) patients with missing stages.  Because of the small 
percent of missingness, casewise deletion was done when analyzing the pathological stages.  
In addition, we do believe that propensity matching eliminates these errors.  Another inherent 
limitation lies in the ability to determining volume association with specific complications of 
esophagogastrectomy including anastomotic leak.  Even though these surgery-specific 
outcomes were not captured in our dataset, it is assumed that their presence would indirectly 
prolonged LOS or increased 30-day readmission rate38.  We found that the MIE approach was a 
negative predictor of hospital LOS but that was negated in matched cohorts (p=0.051).  
However, no inferences can be made whether this is due to an equal rate of surgery-specific 
complications or secondary to the institutions’ abilities to mitigate the complications so that 














that case volume have an indirect positive effect on shortening hospital stay but our findings on 
this were inconclusive.  Our study was also unable to account for specific surgical techniques 
(Ivor Lewis versus McKeown versus transhiatal), transfusions, and operative time which are 
factors that may mitigate surgical outcomes38.  However, we do believe that despite these 
limitations, these statistical reviews of NCDB still has value in defining certain, though not all, 
factors that contribute to overall outcomes of complex surgical procedures such as 
esophagectomy33,39.  
In conclusion, our analyses of the NCDB esophagogastrectomy database demonstrates 
that  perioperative outcomes  of open cases had a direct linear correlation with case volume.  
The effect of case volume on the MIE outcomes, however,  was only apparent when comparing 
the highest and lowest volume centers.  This may be due to the fact that small incremental 
changes in MIE volume do not confer any short-term advantages, particulary since the overall 
MIE outcomes were shown to be better in a parallel, propensity-matched analysis.  It is unclear 
whether the volume outcome relationships also confer a true long-term oncologic benefit.  





































1. D’Amico TA. Outcomes After Surgery for Esophageal Cancer. Gastrointest Cancer Res 
2007;1(5):188-96. 
2. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 
2013;381(9864):400-412. 
3. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative 
Resection for Esophageal Adenocarcinoma: Analysis Of 100 En Bloc Esophagectomies. 
Ann Surg 2001;234(4):520-31. 
4. Zahoor H, Luketich JD, Levy RM et al. A propensity-matched analysis comparing 
survival after primary minimally invasive esophagectomy followed by adjuvant therapy to 
neoadjuvant therapy for esophagogastric adenocarcinoma. J Thorac Cardiovasc Surg 
2015;149(2):538-47. 
5. Biere SS, Maas KW, Bonavina L et al. Traditional invasive vs. minimally invasive 
esophagectomy: a multi-center, randomized trial (TIME-trial). BMC Surgery 2011;11:2. 
6. Biere SS, van Berge Henegouwen MI, Maas KW et al. Minimally invasive versus open 
oesophagectomy for patients with oesophageal cancer: a multicenter, open-label, 
randomized controlled trial. Lancet 2012;379(9829):1887-92.  
7. Luketich JD, Pennathur A, Franchetti Y et al. Minimally Invasive Esophagectomy: 
Results of a Prospective Phase II Multicenter Trial- the Eastern Cooperative Oncology 
Group (E2202) study. Ann Surg 2015;261(4):702-7. 
8. Zhou C, Zhang L, Wang H et al. Superiority of Minimally Invasive Oesophagectomy in 
Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A 
Meta-Analysis. PLoS One 2015;10(7).  
9. Mamidanna R, Bottle A, Aylin P, Faiz O, Hanna GB. Short-term outcomes following open 
versus minimally invasive esophagectomy for cancer in England: a population-based 














10. Sihag S, Wright CD, Wain JC et al. Comparison of perioperative outcomes following 
open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume 
centre†. Euro J Cardiothorac Surg 2012;42(3):430-7. 
11. Sihag S, Kosinski AS, Gaissert HA, Wright CD, Schipper PH. Minimally Invasive Versus 
Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical 
Outcomes From The Society of Thoracic Surgeons National Database. Ann Thorac Surg 
2016;101(4):1281-9. 
12. Lazzarino AI, Nagpal K, Bottle A, Faiz O, Moorthy K, Aylin P. Open versus minimally 
invasive esophagectomy: trends of utilization and associated outcomes in England. Ann 
Surg 2010;252(2):292-8. 
13. Luketich JD, Pennathur A, Awais O et al. Outcomes After Minimally Invasive 
Esophagectomy: Review of Over 1000 Patients. Ann Surg 2012;256(1):95-103. 
14. Palazzo F, Rosato EL, Chaudhary A et al. Minimally Invasive Esophagectomy Provides 
Significant Survival Advantage Compared with Open or Hybrid Esophagectomy for 
Patients with Cancers of the Esophagus and Gastroesophageal Junction. J Am Coll 
Surg 2015;220(4):672-9. 
15. Dantoc MM, Cox MR, Eslick GD. Does minimally invasive esophagectomy (MIE) provide 
for comparable oncologic outcomes to open techniques? A systematic review. J 
Gastrointest Surg 2012;16(3):486-94. 
16. van Workum F, Berkelmans GH, Klarenbeek BR et al. McKeown or Ivor Lewis totally 
minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal 
junction: systematic review and meta-analysis. J Thorac Dis 2017;9(Suppl 8):S826-S33. 
17. Pham TH, Perry KA, Dolan JP et al. Comparison of perioperative outcomes after 
combined thoracoscopic-laparoscopic esophagectomy and open Ivor–Lewis 














18. Zingg U, McQuinn A, DiValentino D et al. Minimally invasive versus open 
esophagectomy for patients with esophageal cancer. Ann Thorac Surg 2009;87(3):911-
9. 
19. Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between 
open and minimally invasive esophagectomy. Ann Surg 2007;245(2):232-40. 
20. Birkmeyer JD, Siewers AE, Finlayson EVA et al. Hospital Volume and Surgical Mortality 
in the United States. New Engl J Med 2002;346(15):1128-37. 
21. Finks JF, Osborne NH, Birkmeyer JD. Trends in Hospital Volume and Operative 
Mortality for High-Risk Surgery. New Engl j Med 2011;364(22):2128-37. 
22. Markar SF, Karthikesalingam A, Thrumurthy S, Low DE. Volume-Outcome Relationship 
in Surgery for Esophageal malignancy: Systematic Review and Meta-analysis 2000-
2011. J Gastrointest Surg 2012;16:1055-1063 
23. Casson AG, van Lanschott JJB. Improving Outcomes After Esophagectomy: the Impact 
of Operative Volume. J Surg Onc 2005;92:262-266. 
24. Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of 
esophagectomy influences the operative mortality rate. J Gastrointest Surg 
1998;2(2):186-92. 
25. Swisher SG, DeFord L, Merriman KW et al. Effect of operative volume on morbidity, 
mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 
2000;119(6):1126-1134. 
26. Fuchs HF, Harnsberger CR, Broderick RC et al. Mortality after esophagectomy is heavily 
impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample. 
Surg Endo 2017;31(6):2491-7. 
27. Brusselaers N, Mattsson F, Lagergren J. Hospital and surgeon volume in relation to 















28. Berry WD, Feldman S (1985). Multiple Regression in Practice (Quantitative Applications 
in the Social Sciences (Series 50). 1st ed.  Newbury Park: Sage Publications, p. 42. 
29. Rosenbaum PR, Rubin DB. The Central Role of the Propensity Score in Observational 
Studies for Causal Effects. Biometrika 1983;70(1): 41-55.  
30. Leuven E, Sianesi B (2003). PSMATCH2: Stata module to perform full Mahalanobis and 
propensity score matching, common support graphing, and covariate imbalance testing. 
Available online: http://ideas.repec.org/c/boc/bocode/s432001.html. 
31. Austin PC. Optimal caliper widths for propensity-score matching when estimating 
differences in means and differences in proportions in observational studies. Pharm Stat 
2011;10(2):150-161 
32. Nilsson M, Kamiya S, Lindblad M, Rouvelas I. Implementation of minimally invasive 
esophagectomy in a tertiary referral center for esophageal cancer. J Thoracic Dis 
2017;9(Suppl 8):S817-S25. 
33. Kutlu OC, Lee JE, Kats MH et al. Open Pancreaticoduodenectomy Case Volume 
Outcome of Laparoscopic Approach: A Population-based Analysis. Ann Surg 2018; 
267(3):552-560. 
34. Metzer R, Bollschweiler E, Vallbohmer D, Maish M, DeMeester RF, Holscher AH. High 
Volume centers for esophagectomy: what is the number needed to achieve low post-
operative mortality. Dis Esophagus 2004;17(4):310-4. 
35. van Lanschott JJ, Hulscher JB, Buskens CJ, Tilanus HW, ten Kate FJ, Obertop H. 
Hospital volume and hospital mortality for esophagectomy. Cancer 2001;91(8):1574-8  
36. van Workum F, Stenstra M, Berkelmans GHK et al. Learning Curve and Associated 
Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study. Ann 
Surg 2017;Epub ahead of print 
37. Tapias LF, Morse CR. Minimally Invasive Ivor Lewis Esophagectomy: Description of a 














38. Bailey SH, Bull DA, Harpole DH et al. Outcomes after esophagectomy: a ten-year 
prospective cohort. Ann Thorac Surg 2003;75(1):217-222. 
39. Varghese TK Jr, Wood DE, Farjah F et al. Variation in esophagectomy outcomes in  















Table 1: Demographics 
 
 Unmatched Cohorts Matched Cohorts 
MIE [N=2371] OE [N=6285] MIE [ N=1819] OE [N=1819] 
Case volume/institution/year, 





Median (range)b 5 (1-42) 6 (1-71) 5 (1-42) 9 (1-28) 
Age, mean (SD) 63.43 (9.49) 63.11 (9.74) 63.67 (9.66) 63.35 (9.51) 
Gender, n(%)   
Male 1982 (27.75) 5161 (72.25) 1507 (82.85) 1537 (84.50) 
Female 389 (25.71) 1124 (74.29) 312 (17.15) 282 (15.50) 
Tumor size, mean (SD)a 36.78 (25.05) 38.15 (25.41) 36.88 (25.14) 37.57 (25.4) 
Median (range)a,c 31 (0-160) 35 (0-190) 32 (0-160) 33 (0-160) 
Charlson score, n(%)   
None 1667 (70.31) 4457 (70.91) 1277 (70.20) 1287 (70.75) 
1 557 (23.49) 1463 (23.28) 435 (23.91) 425 (23.36) 
>/=2 147 (6.2) 365 (5.81) 107 (5.88) 107 (5.88) 
Clinical Stage, n(%)a   
TIS  53 (2.27) 113 (1.85) 32 (1.78) 20 (1.12) 
T1 477 (20.39) 1099 (17.96) 378 (21.05) 334 (18.79) 
T2 440 (18.81) 1127 (18.42) 362 (20.16) 334 (18.79) 
T3 1094 (46.77) 2896 (47.34) 809 (45.04) 846 (47.58) 
T4 38 (1.62) 138 (2.26) 26 (1.45) 34 (1.91) 
Pathological Stage, n(%)   
0 137 (5.90) 319 (5.20) 80 (4.48) 73 (4.05) 
1 754 (32.46) 1827 (29.77) 591 (33.07) 549 (30.48) 
2 705 (30.35) 1957 (31.89) 547 (30.61) 595 (33.04) 
3 689 (29.66) 1913 (31.17) 542 (30.33) 545 (30.26) 
4 38 (1.64) 121 (1.97) 27 (1.51) 39 (2.17) 
Radiation, n(%)   
None 856 (36.1) 2210 (35.16) 709 (38.98) 650 (35.73) 
Neoadjuvant 1395 (58.84) 3681 (58.57) 1013 (55.69) 1054 (57.94) 
Adjuvant 97 (4.09) 328 (5.22) 87 (4.78) 102 (5.61) 
Chemotherapy, n(%)   
None 720 (30.37) 1805 (28.72) 581 (31.94) 535 (29.41) 
Neoadjuvant 1382 (58.29) 3750 (59.67) 1015 (55.80) 1066 (58.60) 
Adjuvant 129 (5.44) 398 (6.33) 115 (6.32) 127 (6.98) 




  MIE – minimally-invasive esophagectomy, OE- open esophagectomy 
a
 Statistically significant for unmatched group 
b
- non-parametric sign test, c- Kruskal-Wallis rank test 















Table 2: Bivariate outcomes 
 
Full Cohort 







30-day mortality, n(%)a 335 (3.89) 73 (3.09) 262 (4.19) 0.018 
90-day mortality, n(%) 720 (8.46) 175 (7.49) 545 (8.84) 0.046 
Length-of-stay, mean (SD)a 14.37 (12.06) 13.61 (11.33) 14.67 (12.32) 0.0005 
30-day unplanned readmission, n(%) 705 (8.2) 184 (7.79) 521 (8.35) 0.399 
R0 resection, n(%) 7873 (92.91) 2202 (93.38) 5671 (92.75) 0.289 
Collected LN, mean (SD)a 13.96 (9.67) 15.38 (9.92) 13.42 (9.52) <0.001 
Positive LN, mean (SD) 1.18 (2.83) 1.13 (2.68) 1.2 (2.88) 0.3397 
5-year overall survival, n(%)a 4792 (55.36) 1374 (57.95) 3418 (54.38) 0.003 
 
a
 Significant difference 
MIE – minimally-invasive esophagogastrectomy 
LN – lymph node 

































esophagectomy 0.68a 0.83 -1.01a 0.98 1.58a -0.04 0.92 0.89 
Case volume 0.99a 0.99a -0.03a 0.99a 0.11a 0.01a 1.00 0.99a 
Age 1.05a 1.05a 0.04a 1.01a -0.02 -0.01a 1.01 1.02a 
Female 1.14 0.99 0.09 1.18 -0.28 -0.16 1.16 0.87a 
Tumor size 1.00 1.01a 0.01a 1.01a 0.01a 0.01a 1.00 1.01a 
Charlson score 
1 1.01 1.11 0.84a 0.99 0.02 0.05 1.39a 1.12 
>/=2 1.97a 1.45a 1.47a 0.96 -0.09 0.01 1.35 1.33a 
Pathological Stage  
1 0.75 0.82 0.16 1.16 0.67 -0.53a 1.62 1.21 
2 0.99 1.06 0.68 3.87a 1.50a 0.02 1.37 2.53a 
3 0.90 1.21 0.74 8.09a 2.97a 2.60a 1.41 4.31a 
4 1.85 3.59a 0.70 11.39a 1.42 3.04a 3.05a 6.57a 
Radiation  
Neoadjuvant 0.80 0.94 -2.20a 0.48a -1.59a -0.57a 0.92 1.14a 
Adjuvant 0.25a 0.29a -3.49a 2.18a -0.97 0.25 0.89 1.27a 




 Significant difference (p<0.05) 
b
 Conversion rate/year 


































esophagectomy 0.40a 0.63 a -0.98 0.98 2.95a 0.07 0.96 0.78a 
Case volume 1.01 1.00 0.00 0.99 0.11a 0.00 1.00 0.99a 
Age 1.06a 1.05a 0.02 1.01 -0.03 -0.01 1.02a 1.02a 
Female 1.00 0.90 0.59 0.70 -0.46 -0.25a 0.98 0.82 
Tumor size 1.00 1.01a 0.03a 1.01a 0.02a 0.00 1.00 1.01a 
Charlson score 
1 1.07 1.30 0.64 1.39 0.01 0.03 1.52a 1.20 
>/=2 2.22a 1.56 0.71 0.98 1.00 -0.05 1.44 1.52a 
Pathological Stage  
1 0.51 0.63 1.11 + 0.87 -0.29a 1.20 0.93 
2 0.66 0.84 1.47 + 1.54a 0.28a 0.86 1.97a 
3 0.67 0.85 1.84 + 2.97a 2.95a 0.89 3.80a 
4 1.04 1.12a 2.84 + 1.09 4.20a 1.81a 4.38a 
Radiation  
Neoadjuvant 0.96 1.08 -1.93a 0.47a -1.82a -0.44a 0.96 1.12 
Adjuvant 0.32 0.48 -2.99a 3.25a -1.77a 0.01 0.91 1.49a 





 Significant difference (p<0.05) 
b
 Conversion rate/year 
+ Could not determine statistically 
















Table 5: Outcomes of MIE after interquartile comparisons based on total annual esophagogastrectomy volume 
 
Dependent variable Quartiles AOR*/β-Coefficients⧧ p-value 
30-day mortality* 4 vs 1 0.44 <0.001 
4 vs 2 0.66 0.048 
4 vs 3 0.79 0.272 
90-day mortality* 4 vs 1 0.56 <0.001 
4 vs 2 0.78 0.077 
4 vs 3 0.88 0.383 
Length of stay⧧[days] 4 vs 1 -1.82 [13.55 vs. 15.56] <0.001 
4 vs 2 -0.78 [13.55 vs. 14.44] 0.086 
4 vs 3 -0.31 [13.55 vs 13.83] 0.474 
Positive Margin* 4 vs 1 0.63  0.001 
4 vs 2 0.86 0.316 
4 vs 3 1.10 0.551 
LN collected⧧ 4 vs 1 6.09 <0.001 
4 vs 2 3.71 <0.001 
4 vs 3 1.20 <0.001 
LN positive⧧ 4 vs 1 0.28 0.003 
4 vs 2 0.22 0.027 
4 vs 3 0.32 0.001 
30-day readmission* 4 vs 1 0.89 0.333 
4 vs 2 1.03 0.828 
4 vs 3 1.16 0.282 
5-year mortality* 4 vs 1 0.62 <0.001 
4 vs 2 0.68 <0.001 
4 vs 3 0.80 0.003 
 















Figure 1: Kaplan-Meier curve for propensity matched cohorts; MIE – minimally-invasive 
esophagogastrectomy; OE – open esophagogastrectomy 
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